RGC
#1676
Regencell Bioscience Holdings Limited - Ordinary Shares
6.3 1 USD
+0.15%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+14.73%
Variazione Mensile
0.00%
Variazione di 6 mesi
-73.94%
Variazione Annuale
-53.26%
Chiusura Precedente
5.5 0
Open
6.3 1
Minimo
6.3 1
Massimo
6.3 1
Volume
10
Financials
- Market Capitalization 3.12 B
- Employee 10
- Founded 2014
- CEO N/A
- Website www.regencellbioscience.com
- Headquarter Cayman Islands
- FIGI UNKNOWN
- Industry Case Farmaceutiche - Specialistico e Generico
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 1240 |  AMRX Amneal Pharmaceuticals, Inc. - Class A Common Stock | 18.06 USD | +2.15% | +1.35% | -5.00% | +71.18% | 5.77 B USD | ||
| 1477 |  INDV Indivior Pharmaceuticals, Inc. - Common Stock | 35.05 USD | +1.42% | -1.57% | -7.62% | +4.32% | 4.14 B USD | ||
| 1833 |  SUPN Supernus Pharmaceuticals, Inc. - Common Stock | 44.03 USD | +0.66% | -1.87% | -4.76% | -18.46% | 2.56 B USD | ||
| 1835 |  BHC Bausch Health Companies Inc. Common Stock | 6.82 USD | +5.25% | +5.57% | -1.30% | -6.58% | 2.55 B USD |